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 One-fifth of the world’s women live in China. Incidence rates of 
breast cancer in most of China are currently low compared with 
those in Western countries. For example, the age-standardized 
incidence rate of breast cancer in the rural county of Qidong is 12.8 
per 100  000 women, which is approximately one-tenth that of white 
women in the United States ( 1 ). However, Shanghai ( 2 ), Hong 
Kong ( 3 ), Japan ( 4 ), and Singapore ( 5 ) have recently experienced rapid 
increases in breast cancer incidence rates, and breast cancer is now the 
most common cancer among women in these regions. Furthermore, 
breast cancer incidence among Asian-American women is increasing 
( 6 ): Rates in Japanese-American women have surpassed the 
age-specific incidence rates in white US women ( 2 ). These trends 
have been attributed to strong cohort effects that have arisen because 
of shifts in risk factor profiles of younger women ( 3 – 5 , 7 ). 
 Established risk factors for breast cancer in women include 
older age, a family history of breast cancer, greater height, adult 
weight gain, high birth weight, alcohol intake, high mammo-
graphic density, postmenopausal hormone use, and certain repro-
ductive factors, including earlier menarche, later age at ﬁ rst 
pregnancy, less breastfeeding, lower parity, and longer interval 
between births ( 8 ). Higher body mass index (BMI) is associated 
with a reduced risk of breast cancer in premenopausal women 
and an increased risk of breast cancer in postmenopausal women 
( 8 ). The hypothesis that all of these risk factors are likely to be 
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  Background  Breast cancer incidence is currently low in China. However, the distribution of reproductive and lifestyle 
risk factors for breast cancer among Chinese women is changing rapidly. We quantified the expected 
effect of changes in breast cancer risk factors on future rates of breast cancer in China. 
  Methods  We first validated and calibrated the Rosner – Colditz log-incidence breast cancer model in Chinese women 
who participated in the Shanghai Women’s Health Study cohort (N = 74  942). We then applied the cali-
brated model to a representative sample of Chinese women who were aged 35 – 49 years in 2001 using 
data from the Chinese National Family Planning and Reproductive Health Survey  (NFPRHS, N = 17  078) to 
predict the age-specific and cumulative breast cancer incidence among all Chinese women of this age 
group. We evaluated the relative impact of changes in modifiable risk factors, including alcohol intake, 
parity, postmenopausal hormone use, and adult weight gain, on cumulative incidence of breast cancer. 
  Results  Breast cancer incidence in China is expected to increase substantially from current rates, estimated at 
10 – 60 cases per 100  000 women, to more than 100 new cases per 100  000 women aged 55 – 69 years by 
2021. We predicted 2.5 million cases of breast cancer by 2021 among Chinese women who were 35 – 49 
years old in 2001. Modest reductions in hormone and alcohol use, and weight maintenance could prevent 
270  000 of these cases. 
  Conclusions  China is on the cusp of a breast cancer epidemic. Although some risk factors associated with economic 
development are largely unavoidable, the substantial predicted increase in new cases of breast cancer 
calls for urgent incorporation of this disease in future health care infrastructure planning. 
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common to women of all ethnicities, including Chinese women, is 
supported by data from an international case – control study ( 9 ) and 
a multiethnic cohort ( 10 ), which demonstrated that, despite varia-
tions in the overall absolute rates of breast cancer, the associations 
between these factors and the risk of breast cancer were similar 
across different ethnic groups. For example, the beneﬁ cial effects 
of earlier ﬁ rst birth, higher parity, and later age at menarche and 
the detrimental effects of family history, adult weight gain, greater 
height, and use of hormone replacement therapy have been con-
ﬁ rmed for Chinese women living in Singapore ( 11 ) and Shanghai 
( 12 , 13 ). Furthermore, breast tumors of Asian women have molecu-
lar and genetic characteristics that are similar to those of white 
women ( 14 ). 
 The distribution of risk factors for breast cancer among 
Chinese women has changed substantially in parallel with China’s 
economic and social development. Secular trends in physical 
growth among Chinese girls have been reported, including 
increases in height ( 15 ) and in the prevalence of overweight and 
obesity ( 16 ). Furthermore, increases in the number of Chinese 
women in the workforce as well as decreases in fertility have drasti-
cally changed the underlying distributions of reproductive factors 
associated with the risk of breast cancer. For example, the average 
birth rate among Chinese women dropped from 5.9 births per 
woman in 1970 to 2.9 births per woman in 1979 and then to 1.7 
births per woman in 2004 ( 17 ). Meanwhile, the average age at 
menarche decreased from 16.5 years in the 1940s to 13.9 years in 
the 1980s ( 18 ). 
 In this study, we evaluated the distribution of demographic and 
reproductive factors associated with breast cancer risk in China 
and quantiﬁ ed the impact of changes in these factors on future 
breast cancer incidence rates. Speciﬁ cally, we validated the 
Rosner – Colditz log-incidence breast cancer model ( 8 , 19 ) in 
Chinese women who participated in the Shanghai Women’s 
Health Study (SWHS) ( 20 ). We then applied the model to Chinese 
national survey data to predict future trends in the incidence of 
breast cancer in China. We conducted a sensitivity analysis to 
assess the relative impact of population-level changes in adult 
weight gain, postmenopausal hormone therapy use, alcohol use, 
and parity on breast cancer incidence to identify possible strategies 
for prevention. 
 Study Population and Methods 
 Study Population 
 Our study population consisted of women who participated in the 
Chinese National Family Planning and Reproductive Health 
Survey in 2001 (NFPRHS 2001). The Chinese National Family 
Planning Commission surveyed a representative and random sam-
ple of premenopausal women aged 15 – 49 years living in 31 prov-
inces in China. Data were collected on 39  585 women from 346 
cities and counties and from 1041 villages. A total of 74% of the 
women who were surveyed lived in rural areas, and the overall 
response rate was 98.3%. Participants in the NFPRHS 2001 were 
assured of the anonymity and confidentiality of their responses to 
increase the reliability of the information collected. The dataset for 
this study population has been described previously ( 21 ); for this 
study, we analyzed relevant reproductive data. Because only a small 
proportion of women in China give birth after age 35, the number 
of children born to a woman by age 35 approximates her lifetime 
parity. To ensure that we would have complete information on 
reproductive history, we restricted our analysis to women who were 
aged 35 years or older before the survey was administered in 2001 
(N = 17  078). 
 Breast Cancer Model and Validation 
 We used the Rosner – Colditz log-incidence breast cancer model, 
which was developed in 1996 and updated in 2000 using data from 
the Nurses ’ Health Study cohort ( 22 ). The model is presented in 
the Appendix and has previously been described in detail ( 8 , 19 ). 
Briefly, it incorporates the effects of various risk factors, including 
history of benign breast disease, family history of breast cancer, 
parity, age at first birth, age at and type of menopause (surgical vs 
natural), use of postmenopausal hormones, alcohol use, height, and 
weight, to estimate the incidence of breast cancer during a woman’s 
lifetime. The Rosner – Colditz model has been validated in white 
 CONTEXT AND CAVEATS 
 Prior knowledge 
 Although the incidence of breast cancer is currently low in most of 
China compared with Western countries, it has increased dramati-
cally over the last several decades in several cities in China and in 
other Asian populations, making breast cancer the most common 
cancer among women in these regions. 
 Study design 
 The Rosner – Colditz log-incidence breast cancer model was vali-
dated in Chinese women who participated in the Shanghai 
Women’s Health Study and then applied to Chinese national sur-
vey data to predict future trends in the incidence of breast cancer 
in China associated with changes in demographic and reproductive 
factors. 
 Contribution 
 Breast cancer incidence in China is expected to increase substan-
tially from the current estimated rate of 10 – 60 cases per 100  000 
women to more than 100 cases per 100  000 women aged 55 – 69 
years by 2021. Modeling predicts 2.5 million cases of breast cancer 
by 2021 among Chinese women who were 35 – 49 years old in 2001. 
Modest reductions in hormone and alcohol use, and weight main-
tenance are predicted to prevent approximately 10% of these 
cases. 
 Implications 
 The substantial predicted increase in breast cancer cases in China 
focuses attention on the adequacy of national infrastructure for 
breast cancer therapy, the possible benefits of population-based 
screening for breast cancer, and possible prevention strategies. 
 Limitations 
 Underreporting of the number of children a woman had given birth 
to in the national survey was possible. The limited availability of 
individual-level data for many of the demographic variables neces-
sitated the use of various assumptions and imputations in the 
model, which may have resulted in uncertainty in some projected 
estimates. The model may slightly overestimate breast cancer inci-
dence at older ages because it does not account for competing risks. 
  From the Editors 
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American women ( 23 ), for whom the observed incidence of breast 
cancer was comparable to the expected incidence based on rates 
for US women obtained from the Surveillance, Epidemiology, and 
End Results (SEER) database [expected-to-observed ratio (E/O) = 
1.0; 95% confidence interval (CI) = 0.98 to 1.03 ( 24 )]. To our 
knowledge, this model has not yet been validated in an Asian 
population. 
 We examined the validity of this model in Chinese women by 
using data from the SWHS. The SWHS is a cohort of 74  942 adult 
Chinese women from urban communities who were recruited 
between 1997 and 2000 and are interviewed in person every 
2 years to collect personal and health-related information ( 20 ). We 
applied the Rosner – Colditz model to the Shanghai cohort to pre-
dict the expected annual incidence of breast cancer for each cohort 
member. We calculated the cumulative incidence rates and 
expected number of cases of breast cancer in the entire cohort for 
each year from the year of recruitment up to 2004. 
 To assess the goodness of ﬁ t of our model within this group of 
Chinese women, we compared the expected and observed number 
of breast cancer cases in the overall cohort and within 5-year age 
groups. Based on the age-speciﬁ c incidence rates from the SEER 
database, the expected number of cases (E SEER ) was 2.79 times 
higher (95% CI = 2.55 to 3.04 times higher) than the observed 
number of cases, whereas after adjusting for risk factors using the 
Rosner – Colditz model, the expected number of cases (E model ) 
approached the observed number of cases. Speciﬁ cally, after apply-
ing US incidence rates to the number of Shanghai women in each 
age group, we expected 1357 cases of breast cancer in the Shanghai 
cohort. The observed number of cases was 487. After adjusting for 
all the risk factors using the Rosner – Colditz model, the expected 
number of cases was 696. Therefore, the model accounted for 76% 
of the discrepancy between United States and Chinese incidence 
rates (ie, difference between the model and the observed Chinese 
rates [1357   696 = 661] divided by the difference between the 
United States and the observed Chinese rates [1357   487 = 870], 
or 661/870 = 0.759). 
 The overall E/O using the Rosner – Colditz model was 1.43 
(95% CI = 1.31 to 1.56), which suggests that such a model devel-
oped in white American women overestimates breast cancer inci-
dence in Chinese women in Shanghai by approximately 40%. 
This overestimate could be due to several differences between the 
predominantly white American women in whom the model was 
developed, and the Asian women to whom it was applied, includ-
ing the lower average height and BMI of the Asian women. 
Differences in physical activity, dietary factors ( 25 ), breastfeeding, 
or variations in the underlying genetic predisposition and endog-
enous hormone levels may also explain the discrepancy ( 26 , 27 ). 
Furthermore, the fact that mammographic screening rates are 
very low in China and relatively high in the United States makes 
the difference in the numbers of detected cancers even more 
pronounced. 
 To correct for this overestimation, we calibrated the log- 
incidence model by adjusting the intercept by 0.357 (the natural 
logarithm of 1.43). After adjustment, the E/O was 1.00 (95% CI = 
0.91 to 1.09) and showed adequate validity given that the 95% CIs 
included 1 in all age groups ( Table 1 ). The goal of this calibration 
was to obtain a model that would provide conservative, lower limit 
predictions of breast cancer incidence. 
 Prediction 
 We applied the adjusted Rosner – Colditz model to the NFPRHS 
dataset to predict annual breast cancer incidence for each woman 
surveyed. For our primary modeling analysis, we used individual-
level data from the NFPRHS dataset as well as data from 
 population-representative health surveys, the published literature, 
and the SWHS cohort. Individual-level data included each  woman’s 
age from 2001 to 2021, age at first birth, parity, and the interval 
between births. Age at menarche, in 10-year age groups, according 
to year of birth was imputed from aggregate data in the 1997 
NFPRHS (J. D. Qu MD, personal communication ). The aggre-
gate-level estimates from other representative sources were imputed 
into the prediction model and randomly assigned to the 17  078 
women in the NFPRHS dataset. 
 BMI and height were assigned according to distributions in the 
SWHS cohort and the China Health and Nutrition Survey. In 
addition, on the basis of mean values from the SWHS, we assumed 
that 17% of women would ever develop benign breast disease, 2% 
would have had a positive family history of breast cancer, 3% 
would have used postmenopausal hormone therapy for 2 years 
after menopause, and 1% would have had an oopherectomy at age 
 Table 1 .  Expected number of breast cancers and ratios of expected to observed numbers of breast cancer cases (E/O ratios) by 
age group, Shanghai Women’s Health Study cohort * 
 Age group, y No. of person-years Observed no. of cases E SEER † 
Before model calibration After model calibration ‡ 
 E model E model /O (95% CI) E model ‡ E model ‡ /O (95% CI) 
 40 – 44 59  891 45 72 58 1.29 (0.96 to 1.72) 41 0.91 (0.68 to 1.22) 
 45 – 49 116  490 107 233 149 1.39 (1.15 to 1.68) 104 0.97 (0.80 to 1.17) 
 50 – 54 81  767 92 213 126 1.37 (1.12 to 1.68) 88 0.96 (0.78 to 1.18) 
 55 – 59 56  089 63 185 91 1.44 (1.12 to 1.84) 64 1.02 (0.80 to 1.31) 
 60 – 64 52  699 63 206 87 1.38 (1.08 to 1.77) 61 0.97 (0.76 to 1.24) 
 65 – 69 65  673 72 292 116 1.61 (1.27 to 2.03) 81 1.13 (0.89 to 1.42) 
 70 – 74 32  474 42 156 65 1.55 (1.15 to 2.10) 45 1.07 (0.79 to 1.45) 
 75 – 79 1237 3 6 4 1.33 (0.43 to 4.12) 3 1.00 (0.32 to 3.10) 
 *  SEER = Surveillance, Epidemiology, and End Results (Program) database; CI = confidence interval. 
 †  Expected number of cases of breast cancer in each age group after standardization to US SEER rates over the same time period. 
 ‡  Calibration was used to address model overprediction. Model intercept reduced by the natural logarithm of 1.43 (ie, 0.357). 
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45. We estimated the average weekly alcohol intake to be 14 g 
(about one glass of wine or beer) and randomly applied this value 
to 10% of the population based on data from other studies in 
China and Hong Kong that showed that approximately 10% of 
women in this age group drink alcohol (T. Hesketh MD, PhD and 
G. Leung MD , personal communication). Because all of the 
women surveyed were premenopausal, we assumed that meno-
pause would occur at age 49 years, which has been well docu-
mented as the mean age at menopause for women of many 
ethnicities, including Chinese women ( 18 ). We examined the 
robustness of our estimates to the choice of these imputed values 
in a sensitivity analysis (see below). 
 Time- and age-speciﬁ c incidence rates, cumulative incidence 
rates, and the expected number of cases were calculated for 17  078 
NFPRHS participants who were aged 35 – 49 years at baseline in 
2001. Our predictions of breast cancer risk extend 20 years forward 
in time, up to 2021, when the NFRPHS participants would be 
55 – 69 years old. We used information from the China 2000 
Census ( 27 ) to approximate the population distribution of Chinese 
women in 2001. Our estimates of cumulative incidence of breast 
cancer derived from the representative sample of Chinese women 
(ie, the NFPRHS participants) were applied to the total number of 
Chinese women aged 35 – 49 years [N = 130  304  574 ( 28 )] to obtain 
overall predictions for this age group across China. 
 Sensitivity Analysis 
 To assess the range of our predictions according to different 
assumptions about demographic changes in China, we recalculated 
the predicted age-specific and cumulative incidence rates, as well as 
the expected numbers of cases, according to different assumptions 
about patterns of weight gain, hormone replacement therapy use, 
alcohol use, age at menopause, and parity (see Appendix). 
 Results 
 Our projection analysis included 17  078 women aged 35 – 49 years 
who participated in the NFPRHS. The mean age of these women 
at the NFPRHS interview was 41 years (SD = 4.6 years). The mean 
birth rate in the overall NFPRHS was 1.94 (SD = 0.6; 2.11 in rural 
areas and 1.43 in urban areas); among women 35 – 49 years old, it 
was 2.10 (SD = 0.6). The mean age at first birth was 24 years 
(SD = 2.9 years; median age at first birth = 26 years, range = 14 – 39 
years). 
 Projected age- and birth cohort – speciﬁ c breast cancer inci-
dence rates up to the year 2021 are shown in  Table 2 and  Figure 1 . 
These breast cancer incidence rates ranged from 39.0 per 100  000 
women for women who were born between 1962 and 1966 and 
were 35 – 39 years old in 2001 to 132.3 per 100  000 women for 
women who were born between 1952 and 1956 and would be 65 –
 69 years old in 2021. The age-speciﬁ c incidence rates were higher 
among more recent birth cohorts; for example, the incidence of 
breast cancer in women aged 55 – 59 years is higher in women born 
between 1962 and 1966 (109.8 per 100  000) than in women born 
between 1952 and 1956 (102.6 per 100  000). On the basis of the 
cumulative incidence rates, the model predicted that 146 cases of 
breast cancer would occur within this sample of 17  078 women by 
2011 and that 326 cases would occur by 2021. When we applied 
the model to the entire Chinese population of women of the same 
age distribution in 2000 as our sample population (N = 130  304  574) 
( 28 ), the predicted number of cases of breast cancer by 2011 was 
approximately 1.1 million. The predicted number of breast cancer 
cases increased to nearly 2.5 million by 2021 ( Table 2 ). 
 Sensitivity Analysis 
 We examined the dependence of these breast cancer incidence pre-
dictions on variations in modifiable risk factors by changing our 
 Table 2 .  Predicted breast cancer incidence among NFPRHS participants by year of birth * 
 Year of birth
 1952 – 1956 1957 – 1961 1962 – 1966 All (1952 – 1966) 
Age-specific incidence per 100 000 women in 2001 – 2021
 Age group in 2001 – 2021, y  
  35 – 39  —  — 39.0 39.0 
  40 – 44  — 63.8 64.7 64.3 
  45 – 49 83.3 86.6 90.0 86.9 
  50 – 54 88.1 92.6 95.5 92.3 
  55 – 59 102.6 107.0 109.8 106.7 
  60 – 64 115.7 120.9  — 118.2 
  65 – 69 132.3  —  — 132.3 
 Cumulative incidence per 100  000 women 
  By 2011 994.6 894.0 711.2 855.3 
  By 2021 2152.0 1963.3 1677.2 1912.7 
 Population size and number of cases 
 NFPRHS population (2001) N = 5495 N = 4940 N = 6643 N = 17  078 
  By 2011 55 44 47 146 
  By 2021 118 97 111 326 
 Chinese population † N = 40  838  382 N = 39  465  761 N = 50  000  431 N = 130  304  574 
  By 2011 406  180 352  807 355  604 1  114  591 
  By 2021 878  829 774  822 838  599 2  492  250 
 *  — = not applicable; NFPRHS = National Family Planning and Reproductive Health Survey. 
 †  Chinese population data from the 2000 census were used to approximate the number of women in each age group in 2001. 
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assumptions about the frequency of postmenopausal hormone use, 
alcohol use, and weight gain ( Figure 2 ). These estimates reflect theo-
retical changes in risk factors that we applied to the general Chinese 
population. Compared with an estimated cumulative incidence of 
1912.7 cases per 100  000 women from the base case model, a model 
that incorporated concurrent increases in the extent of postmeno-
pausal hormone use, alcohol consumption, and weight gain predicted 
an additional 76 cases of breast cancer per 100  000 women by 2021. 
This increase corresponds to approximately 100  000 additional cases 
of breast cancer in Chinese women who will be aged 55 – 69 years in 
2021. A reduction in parity, from the national average of 2.1 births 
per woman to 1.1 births per woman (which is similar to birth rates in 
several developed Asian and European countries), would account for 
an additional 200  000 cases in this subgroup of Chinese women. 
Conversely, a model that incorporated a stable weight in adulthood 
resulted in 140 fewer cases per 100  000 women, or a total of 190  000 
fewer cases. A model that included low alcohol consumption, stable 
weight and infrequent use of postmenopausal hormones indicated 
possible prevention of 270  000 new cases of breast cancer overall in 
this subset of women across China by 2021. Under these conserva-
tive assumptions, the cumulative incidence of breast cancer was pre-
dicted to be 1704 cases per 100  000 women by 2021, corresponding 
to a total of 2.2 million incident cases across China by 2021 . 
 Discussion 
 Breast cancer incidence has increased dramatically over the past 30 
years in several cities in China and in other Asian populations. Our 
modeling results show that this trend is likely to continue across 
China. On the basis of our modeling results, we predict that the 
nationwide incidence of breast cancer among women who will be 55 –
 69 years in 2021 will increase from the current rate, which has been 
estimated at 10 – 60 cases per 100  000 women ( 2 , 29 ). Applying these 
rates to the 130 million Chinese women in this age group, we estimate 
nearly 2.5 million cases of breast cancer from 2001 to 2021 among 
women who were 35 – 49 years old in 2000. Even under very conserva-
tive assumptions of low alcohol use, no postmenopausal hormone use, 
and no adult weight gain, we predict that the cumulative incidence of 
breast cancer will increase to at least 2.2 million new cases of breast 
cancer among this subgroup of women across China over the 20-year 
period from 2001 to 2021. These results point to an emerging epi-
demic of breast cancer in China, where breast cancer incidence rates 
are approaching those in Western nations, in which breast cancer is the 
most commonly diagnosed female cancer. Our findings raise impor-
tant issues regarding future health care infrastructure needs, the role of 
breast cancer screening programs, and possible prevention strategies. 
 The strengths of this study include our use of a validated and 
calibrated model of breast cancer and a representative population 
that included both rural and urban Chinese women. The valida-
tion used regional data from Shanghai (SWHS), and the predic-
tion modeling was performed using representative national survey 
data (NFPRHS). To our knowledge, this is the ﬁ rst quantitative 
  
 Figure 1 .  Predicted age-speciﬁ c breast cancer incidence according to 
year of birth. 
 Figure 2 .  Sensitivity analysis of age-speciﬁ c 
cumulative incidence of breast cancer per 
100  000 women by 2021 according to differ-
ent population assumptions. PMH = post-
menopausal hormone use. 
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analysis of the impact of demographic change on breast cancer 
trends in a developing country. 
 Nonetheless, our analysis has several limitations. First, although 
the NFPRHS dataset we used is based on a representative sample 
of all Chinese women of reproductive age, some women who 
responded to the survey may have deliberately underreported the 
number of children they had given birth to in order to avoid the 
consequences of violating China’s one-child family policy. An 
underestimate in a protective factor such as parity would result in 
an overestimation of the number of projected cases of breast can-
cer.  However, NFPRHS participants were ensured anonymity and 
conﬁ dentiality in an attempt to reduce such underreporting. 
Second, the limited availability of individual-level data for many 
of the demographic variables necessitated the use of various 
assumptions and imputations in the model, which may have 
resulted in uncertainty in the projected estimates, especially when 
predicting breast cancer after menopause. In particular, we 
assumed that the distributions of BMI, height, hormone therapy 
use, age at menopause, and benign breast disease in Chinese 
women living in China were similar to those of Chinese women 
living in Shanghai. We also assumed that these imputed variables 
were not correlated with each other. Third, our model does not 
account for competing risks and may, therefore, slightly overesti-
mate breast cancer incidence at older ages. However, as the popu-
lation of China ages, chronic diseases, including breast cancer, are 
likely to become more prevalent. Despite these limitations, we 
believe that our results reﬂ ect the best possible estimates given the 
available data and our results send an important public health 
message that warrants immediate action regarding health care 
planning in China. Additional studies that include representative 
individual-level data on breast cancer risk factors and breast 
cancer incidence are needed to provide more comprehensive 
and accurate estimates of breast cancer burden. 
 One important consideration in the interpretation of our ﬁ nd-
ings is whether a model that was developed in white American 
women is valid when used to predict breast cancer in Chinese women. 
By using information on risk factors that are common to women 
of all ethnicities, we found that the Rosner – Colditz model was able 
to explain as much as 76% of the difference in rates between 
American and Chinese women. Nonetheless, the model overesti-
mated Chinese breast cancer incidence rates by approximately 
40%. This overestimate may be due to differences between white 
American women and Chinese women in diet, genetics, body 
shape, or other breast cancer risk factors or may reﬂ ect systematic 
differences in how breast cancer screening is recorded on cancer 
records. Regardless of whether the model itself or quality of the 
data used to validate it account for this discrepancy, our estimates, 
after calibrating down by 40%, are conservative. 
 There are several reasons that the true burden of breast cancer 
may be even higher than our estimates. Our predictions apply to a 
small fraction of the Chinese female population (those aged 35 – 49 
years in 2001, 21% of the female population); thus, the overall 
number of breast cancer cases that will develop by 2021 is likely to 
be far more than what we have estimated. Younger women (ie, 
those born after 1967) were not included in this analysis because 
we wanted to ensure that the reproductive information was accu-
rate. However, because breast cancer risk factors are more preva-
lent in this younger group, our calculations may underestimate the 
true breast cancer incidence rates across all Chinese women. In 
addition , the predictions from the sensitivity analyses could be 
substantially higher if concurrent changes were to occur in multi-
ple risk factors that interact with each other. Nonetheless, our 
ﬁ ndings are consistent with trends of increasing breast cancer inci-
dence rates predicted in an earlier study ( 29 ) and observed in other, 
more developed Asian regions ( 3 , 4 , 30 , 31 ) that have undergone 
temporal shifts in reproductive and lifestyle risk factors (toward 
lower fertility, increased weight, more frequent use of postmeno-
pausal hormones, and higher alcohol consumption). 
 Our sensitivity analyses allowed us to model the effects of 
changes in modiﬁ able risk factors on predicted breast cancer inci-
dence rates. Modest increases in the use of postmenopausal hor-
mones and alcohol and in weight were predicted to cause an 
additional 100  000 new cases of breast cancer by 2021. Although 
increases in the prevalence of these behavioral risk factors may 
contribute to the future burden of disease, these risk factors also 
provide targets for public health interventions: Moderation in these 
three factors could prevent 270  000 new cases of breast cancer in 
among women aged 35 – 49 years in 2001. In addition to preventing 
premenopausal breast cancer, avoidance of weight gain through 
physical activity and good nutrition is likely to beneﬁ t overall 
health by preventing diabetes and cardiovascular disease, which are 
established health care priorities in China ( 32 , 33 ). Moreover, 
among Western women who drink alcohol, sufﬁ cient dietary folate 
has been shown to mitigate the excess risk of breast cancer associ-
ated with alcohol consumption and, hence, a potential prevention 
effort could lie in emphasizing increasing folic acid intake. The 
recent declines in US breast cancer rates that have been attributed 
to decreases in use of hormone therapy ( 34 , 35 ) have also been 
noted in Asian women ( 36 ), making reductions in hormone use a 
realistic health care goal for breast cancer prevention in China. 
 Given the parallel shifts in the underlying breast cancer risk 
factors that have been noted across the developing world, our ﬁ nd-
ings may have implications for many other developing countries 
worldwide. For example, our results raise questions about the 
adequacy of national infrastructure for breast cancer therapy and 
the possible beneﬁ ts of population-based screening for breast can-
cer. Although mammography has been beneﬁ cial in reducing the 
health burden of malignant breast cancers in Western countries 
( 37 ), cost-effectiveness analyses in Hong Kong suggest that mam-
mography may not be cost-effective for Asian populations ( 38 , 39 ). 
Further research on the regional patterns of breast cancer inci-
dence, including possible differences between urban and rural 
areas, is needed to guide screening policy . 
 Our ﬁ ndings highlight the likely consequences of recent 
changes in reproductive and other lifestyle patterns on breast can-
cer incidence in China and, perhaps, other developing countries. 
The decline in fertility in China is part of a worldwide trend 
toward having fewer children that is associated with economic and 
social development and is not thought to be attributable to any 
single policy measure ( 21 ). Breast cancer prevention is only one of 
many considerations that should inﬂ uence population planning; 
economic development, environmental sustainability, and cultural 
priorities are also critical considerations. However, not all propos-
als to achieve economic and demographic goals have equivalent 
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health effects. To prevent breast cancer, fertility policies should 
emphasize early, rather than late, childbearing and shorter, rather 
than longer, spacing between births and breast-feeding. 
 In summary, we predict a substantial increase in breast cancer 
incidence in China over the next two decades. The underlying 
causes of this emerging epidemic, namely shifting reproductive 
trends and growth and lifestyle changes that are associated with 
economic development, are applicable to many developing nations 
worldwide. Our ﬁ ndings may have implications for both health 
care planning within China and across the developing world. 
Weight maintenance and avoidance of alcohol and postmeno-
pausal hormones may form targets for public health interventions 
and be used to mitigate the future burden of this disease. 
 Appendix 
 Description of the Log-Incidence Model of Breast Cancer 
 We ﬁ t our log-incidence model of breast cancer to incident cases of invasive breast 
cancer identiﬁ ed during follow-up of the Nurses ’ Health Study cohort. The 
approach to model ﬁ tting was to assume that incidence at time  t ( It ) is proportional 
to the number of cell divisions ( Ct ) accumulated throughout life up to age t, that is
 I t =  kC t  . [1] 
 The cumulative number of breast cell divisions is calculated as follows: 
   C C C C C xt o i i o
i
t
i
i
t
= =∏ ∏+
=
−
=
−
X ( / ) .1
0
1
0
1
l  [2]
 Thus, λ i  =  C i +1/ C i represents the rate of increase of breast cell divisions 
from age  i to age  i + 1. Log (λ i ) is assumed to be a linear function of risk factors 
that are relevant at age  i . The set of relevant risk factors and their magnitude 
may vary according to the stage of reproductive life. The overall model is 
given by 
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 where  t = age;  t o = age at menarche;  t m = age at menopause;  t * = min (age, age 
at menopause);  m t = 1 if postmenopausal at age  t , 0 otherwise;  s t = parity at age  t ; 
 t i = age at  i th birth,  i = 1,  … ,  s ;  b t t b bi it
i
St
it= = -å =
=
birth index ( ) ;*
1
1  if parity is 
greater than or equal to  i at age  t , = 0 otherwise;  m A = 1 if natural menopause, = 0 
otherwise;  m B = 1 if bilateral oophorectomy, = 0 otherwise; bbd = 1 if benign breast 
disease = yes, = 0 otherwise; fhx = 1 if family history of breast cancer in mother or 
sister = yes, = 0 otherwise; pmh A = number of years on oral estrogen; pmh B = 
number of years on oral estrogen and progesterone; pmh C = number of years on 
other types of postmenopausal hormones; pmh cur, t  = 1 if current user of postmeno-
pausal hormones at age  t , = 0 otherwise; pmh past, t  = 1 if past user of postmenopausal 
hormones at age  t , = 0 otherwise; BMI j = body mass index at age  j (kg/m 2 ); alc j = 
alcohol consumption (grams) at age  j ;  h = height (inches). 
 The terms for BMI, height, and alcohol in relation to menopause and use of 
hormones are summarized below:
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 where β0 represents the rate of increase in incidence prior to menopause among 
nulliparous women with no benign breast disease and no family history; β 1  and 
β 2 represent modiﬁ cation to the rate of increase in incidence for parous women 
according to the number and precise spacing of births; γ 1 and γ 2 represent rates 
of increase in incidence after menopause according to type of menopause among 
women without benign breast disease not currently using postmenopausal hor-
mones; δ 1 , δ 2 and δ 3 represent modiﬁ cations to the rate of increase in incidence 
after menopause among women currently using postmenopausal hormones 
according to the duration of the speciﬁ c types of postmenopausal hormones 
used; δ 4 and δ 5 represent the immediate effect of starting and stopping post-
menopausal hormone use on rates of increase in incidence after menopause; and 
f represents the effect of family history of breast cancer on the number of breast 
cell divisions at birth (ie,  C o ). 
 β 3 represents the effect of BMI either before menopause or after menopause 
on breast cancer incidence for a woman who is currently on postmenopausal 
hormones. β * 3  represents the effect of BMI after menopause on breast cancer 
incidence while not on postmenopausal hormones. β 4  and β 3 are the effects of 
height deﬁ ned similarly to β 3  and β* 3  and β 5 ,β *5  and β **5  represent effects of alcohol 
before menopause, after menopause on postmenopausal hormones, and after 
menopause not on postmenopausal hormones, respectively. The rationale for the 
separate terms is the ﬁ nding in exploratory analyses and from the literature ( 40 ) 
that effects of BMI and possibly height and alcohol on breast cancer incidence are 
different before and after menopause and that the effect of BMI on breast cancer 
incidence after menopause differs according to whether a woman is or is not cur-
rently on postmenopausal hormones ( 41 ). α 1 , α 2 , α 3 , and α 4 represent modiﬁ cations 
to 1) the number of breast cell divisions at birth, 2) the rates of increase in the 
number of cell divisions after birth, but before menarche, 3) the rates of increase 
in the number of cell divisions after menarche, but before menopause, and 4) the 
rates of increase in the number of cell divisions after menopause among women 
with benign breast disease, respectively. The rationale for these extra terms 
involving benign breast disease is that the relative risk for benign breast disease 
varies according to age, with the relative risk being strongest among younger 
women and diminishing over time. 
 The general rationale for a log-incidence model of a speciﬁ c cancer is that the 
number of precancerous cells increases multiplicatively with time, whereas the risk 
factor proﬁ le from birth to current age (eg, 35 years) differentially affects the rate 
of increase in incidence. Speciﬁ cally, for the breast cancer incidence model 
described above, the number of precancerous cells is assumed to increase annually 
at the rate of (β0) prior to menopause for nulliparous women; at the rate of exp(β0+ 
β1s) prior to menopause for parous women with parity =  s , and so forth. Finally, 
the number of precancerous cells increases immediately after the ﬁ rst birth 
by exp[β2( t 1 - t 0 )] The incidence rate of breast cancer is, therefore, assumed to be 
approximately proportional to the number of precancerous cells. 
 Incidence Calculations 
 Cumulative incidence was calculated according to the following formula:
CI 1 e ,= − ∑− ( )ri
 where  r i is the incidence rate for each year. Because of the lag in recruitment from 
1997 to 2000 and loss to follow-up, individual women were followed for different 
lengths of time. We therefore calculated each woman’s expected cumulative inci-
dence for the length of time she was actually followed in the cohort. By summing 
over the predicted cumulative incidences for each woman, we obtained the 
expected number of cases in the entire cohort. We further subdivided the follow-up 
time into 5-year age groups and calculated the average incidence rates within 
each age group, thus estimating the age-speciﬁ c incidence rates predicted in this 
population. The sum of the cumulative incidences for each 5-year age group 
yielded the expected number of cases within each age group. Conﬁ dence 
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intervals for E/O ratio described in validation section were calculated according 
to the following formula: 
E/O exp ±1.96 √ 1/O  .
 Sensitivity Analysis Assumptions  
 1.  Stable weight: no changes in weight from age 18 years onward; mean 
BMI = 23 kg/m 2 . 
 2.  Average weight gain: 0.1 annual increase in BMI from BMI 20 kg/m 2 at 
age 18 ( 42 ). 
 3.   Above-average weight gain: 0.2 annual increase in BMI from BMI of 20 kg/m 2 
at age 18. 
 4.  Low alcohol use: 2% of women drinking an average of 2 g of alcohol per 
day. 
 5.  High alcohol use: 40% of women drinking an average of 2 g of alcohol per 
day. 
 6.   No postmenopausal hormone use: 0% of women using hormones. 
 7.   High postmenopausal hormone use: 6% of women using hormone therapy 
(2% estrogen and progesterone, 2% estrogen only, 2% other hormone 
therapy) for 2 years following menopause. 
 8.  Fertility rate: 1.1 births per woman. 
 9.  High alcohol use, above-average weight gain, and high postmenopausal 
hormone use (ie, assumptions 3, 5, and 7). 
 10.  Stable weight, low alcohol use, and no postmenopausal hormone uses 
(ie, assumptions 1, 4, and 6). 
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